Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nevro Corp (NVRO)

Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 214,865
  • Shares Outstanding, K 36,729
  • Annual Sales, $ 425,170 K
  • Annual Income, $ -92,210 K
  • 60-Month Beta 0.94
  • Price/Sales 0.51
  • Price/Cash Flow N/A
  • Price/Book 0.78
Trade NVRO with:

Options Overview Details

View History
  • Implied Volatility 78.24% ( +12.20%)
  • Historical Volatility 196.09%
  • IV Percentile 56%
  • IV Rank 49.82%
  • IV High 130.59% on 05/06/24
  • IV Low 26.27% on 05/31/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 48
  • Volume Avg (30-Day) 123
  • Put/Call OI Ratio 2.57
  • Today's Open Interest 20,333
  • Open Int (30-Day) 19,447

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.82
  • Number of Estimates 8
  • High Estimate -0.67
  • Low Estimate -0.98
  • Prior Year -0.65
  • Growth Rate Est. (year over year) -26.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.67 +24.63%
on 09/11/24
6.49 -10.32%
on 08/30/24
+0.23 (+4.11%)
since 08/16/24
3-Month
4.38 +32.82%
on 08/07/24
10.37 -43.88%
on 07/17/24
-2.99 (-33.94%)
since 06/18/24
52-Week
4.38 +32.82%
on 08/07/24
22.64 -74.29%
on 12/15/23
-14.31 (-71.09%)
since 09/18/23

Most Recent Stories

More News
Nevro: Q2 Earnings Snapshot

Nevro: Q2 Earnings Snapshot

NVRO : 5.82 (-0.51%)
Nevro: Q1 Earnings Snapshot

Nevro: Q1 Earnings Snapshot

NVRO : 5.82 (-0.51%)
Why Nevro Stock Lagged the Market on Thursday

Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.

NVRO : 5.82 (-0.51%)
Nevro: Q4 Earnings Snapshot

Nevro: Q4 Earnings Snapshot

NVRO : 5.82 (-0.51%)
Nevro: Q3 Earnings Snapshot

Nevro: Q3 Earnings Snapshot

NVRO : 5.82 (-0.51%)
Nevro to Report Third Quarter 2023 Financial Results

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.82 (-0.51%)
New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.82 (-0.51%)
Nevro Announces Participation in Upcoming Investor Conferences

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 5.82 (-0.51%)
New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 5.82 (-0.51%)
Why Shares of Nevro Are Down Wednesday

The medical device maker saw increased revenue, but earnings lagged estimates.

NVRO : 5.82 (-0.51%)

Business Summary

Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation...

See More

Key Turning Points

3rd Resistance Point 6.61
2nd Resistance Point 6.45
1st Resistance Point 6.13
Last Price 5.82
1st Support Level 5.65
2nd Support Level 5.49
3rd Support Level 5.18

See More

52-Week High 22.64
Fibonacci 61.8% 15.67
Fibonacci 50% 13.51
Fibonacci 38.2% 11.36
Last Price 5.82
52-Week Low 4.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar